Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population

Wang RH, Chen Y, Lou YL, Lu YL, Xu HM

Therapeutics and Clinical Risk Management 2025, 21:125-135

Published Date: 3 February 2025